ArticlebioRxiv : the preprint server for biology2023

Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: a pilot study.

Shinnyi Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.